Monoclonal Antibody Therapy in Parkinson’s Disease — The End?

Alan L Whone

doi:10.1056/NEJMe2207681

Monoclonal Antibody Therapy in Parkinson’s Disease — The End?

Alan L Whone

Research output: Contribution to journal › Article (Academic Journal) › peer-review

23 Citations (Scopus)

391 Downloads (Pure)

Abstract

[No abstract]

Original language	English
Pages (from-to)	466-467
Number of pages	2
Journal	New England Journal of Medicine
Volume	387
Issue number	5
Early online date	3 Aug 2022
DOIs	https://doi.org/10.1056/NEJMe2207681
Publication status	Published - 4 Aug 2022

Access to Document

10.1056/NEJMe2207681

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via Massachusetts Medical Society at https://www.nejm.org/doi/10.1056/NEJMe2207681. Please refer to any applicable terms of use of the publisher
Final published version, 371 KB

Handle.net

Persistent link

Cite this

@article{5f24f3202842443684f724497a178a06,

title = "Monoclonal Antibody Therapy in Parkinson{\textquoteright}s Disease — The End?",

abstract = "[No abstract]",

author = "Whone, \{Alan L\}",

year = "2022",

month = aug,

day = "4",

doi = "10.1056/NEJMe2207681",

language = "English",

volume = "387",

pages = "466--467",

journal = "New England Journal of Medicine",

issn = "0028-4793",